Covered recipient · General Payments record
MIGUEL A UNZUETA
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$3,710.77
- Reported across 149 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $426.66 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $160.96 | 4 |
| Oyster Point Pharma, Inc. | $74.65 | 3 |
| Alcon Laboratories Inc | $59.13 | 4 |
| Bausch & Lomb Americas Inc. | $42.48 | 2 |
| RxSight Inc | $32.07 | 2 |
| Dompe US, Inc. | $24.12 | 1 |
| Nova Eye, Inc. | $18.50 | 1 |
| Amgen Inc. | $14.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $121.47 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106260376 | CMS |
| ABBVIE INC. | $13.92 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106260378 | CMS |
| ABBVIE INC. | $11.47 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106260380 | CMS |
| ABBVIE INC. | $14.10 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106260382 | CMS |
| Alcon Vision LLC | $12.29 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112011301 | CMS |
| Alcon Vision LLC | $4.94 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112011303 | CMS |
| Alcon Vision LLC | $21.16 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110567663 | CMS |
| Alcon Vision LLC | $20.74 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110567661 | CMS |
| Amgen Inc. | $14.75 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116188562 | CMS |
| Bausch & Lomb Americas Inc. | $19.17 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140413967 | CMS |
| Bausch & Lomb Americas Inc. | $23.31 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140413965 | CMS |
| Dompe US, Inc. | $24.12 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151411855 | CMS |
| Nova Eye, Inc. | $18.50 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152400273 | CMS |
| Oyster Point Pharma, Inc. | $28.23 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147402466 | CMS |
| Oyster Point Pharma, Inc. | $27.61 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147417068 | CMS |
| Oyster Point Pharma, Inc. | $18.81 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147433925 | CMS |
| RxSight Inc | $15.99 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144229871 | CMS |
| RxSight Inc | $16.08 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144229873 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.